Merck & Co Inc
NYSE: MRK
$100.60
+$1.35 (+1.4%)
Real Time Data Delayed 15 Min.
MRK Articles
Drug giants Merck and Pfizer reported better-than-expected second-quarter 2014 results before markets opened Tuesday morning.
Published:
Last Updated:
Jon OggThe short interest data for the July 15 settlement date is out and we have compared the defensive dividend stocks, aside of utilities, to what has happened since the June 30 settlement date....
Published:
Last Updated:
Wikimedia CommonsIn a week that saw more than its share of volatility some top insiders decided it was time to lighten up on their holdings. As we have mentioned in the past, selling by insiders,...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Jon OggThe short interest data for the June 30...
Published:
The second quarter of 2014 has come and gone, which means that we are now already half way through 2014. The five-year bull market has managed to continue making its gains. The Dow Jones Industrial...
Published:
Last Updated:
The short interest data for the first two weeks of June show that short interest was higher in almost all our go-to list of defensive high-yield stocks that are not utilities.
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ThinkstockThe short interest data for the final two...
Published:
Here are the four top biotech names we found that all have hepatitis C drugs in their current pipelines at one stage or another and that could be the next takeover targets.
Published:
24/7 Wall St. wanted to look at the leaders and laggards in the Dow Jones Industrial Average. It turns out that as of Friday's closing bell, seven of the 30 Dow stocks were trading up by more than...
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstockMay 29, 2014: Markets opened higher on...
Published:
Last Updated:
Pfizer looks like it is out of the bid now for AstraZeneca. What looks increasingly obvious for a lackluster performance is that Pfizer may now simply be having an identity crisis.
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstockMay 8, 2014: Markets opened lower on Thursday...
Published:
Last Updated:
These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, May 8, 2014. They include Chevron, Exxon, FedEx, Merck, Tesla, Twitter, Disney and Yelp.
Published:
thinkstockMay 6, 2014: Markets opened lower on Monday and sank slowly and surely for the rest of the day. The dollar weakened against the yen overnight removing some enthusiasm for risk in today’s...
Published:
Last Updated:
Merck has had its consumer products business on the market since the beginning of this year, and Tuesday it announced that it had sold the business to Germany-based Bayer for $14.2 billion.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.